Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Acutus Medical, Inc. AFIB
$0.91
-$0.04 (-4.15%)
На 18:02, 12 мая 2023
+64.84%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
26874402.00000000
-
week52high
2.15
-
week52low
0.48
-
Revenue
16363000
-
P/E TTM
-1
-
Beta
0.79957300
-
EPS
-1.61000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Neutral | Neutral | 16 авг 2022 г. |
| BTIG | Buy | Buy | 24 июн 2022 г. |
| BTIG | Buy | Neutral | 27 апр 2022 г. |
| Goldman Sachs | Neutral | Neutral | 14 апр 2022 г. |
| BTIG | Neutral | Buy | 20 янв 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sohn Tom | D | 57190 | 6525 | 01 февр 2023 г. |
| Mathews Kevin | D | 24153 | 3540 | 01 февр 2023 г. |
| Piscitello Charlie | D | 44038 | 6627 | 01 февр 2023 г. |
| Roman David | D | 248159 | 10196 | 01 февр 2023 г. |
| Mukai Takeo | D | 36448 | 2855 | 01 февр 2023 г. |
| Huennekens R Scott | A | 5880 | 5880 | 01 окт 2022 г. |
| Huennekens R Scott | A | 10920 | 2520 | 01 окт 2022 г. |
| Mukai Takeo | A | 39303 | 20000 | 01 сент 2022 г. |
| Garland Jason K | A | 32500 | 32500 | 01 сент 2022 г. |
| Garland Jason K | A | 14000 | 14000 | 01 сент 2022 г. |
Новостная лента
Acutus Medical, Inc. (AFIB) Q3 2022 Earnings Call Transcript
Seeking Alpha
13 ноя 2022 г. в 08:50
Acutus Medical, Inc. (NASDAQ:AFIB ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Relations David Roman - President & Chief Executive Officer Takeo Mukai - Vice President, Finance & Accounting, Interim Chief Financial Officer Conference Call Participants Marie Thibault - BTIG John Young - Canaccord Genuity Margaret Kaczor - William Blair Philip Coover - Goldman Sachs Javier Fonseca - Spartan Capital Operator Good day, and thank you for standing by. Welcome to the Acutus Medical Third Quarter 2022 Earnings Call.
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 18:48
Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 13.25% and 3.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Acutus Medical to Announce Third Quarter 2022 Financial Results
GlobeNewsWire
27 окт 2022 г. в 16:01
CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2022 financial results on Thursday, November 10, 2022. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Acutus Medical, Inc. (AFIB) CEO David Roman on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
12 авг 2022 г. в 17:54
Acutus Medical, Inc. (NASDAQ:AFIB ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Relations David Roman - Chief Executive Officer & Chief Financial Officer Conference Call Participants William Plovanic - Canaccord Allen Gong - JPMorgan Marie Thibault - BTIG Javier Fonseca - Spartan Capital John Young - Canaccord Operator Good day and welcome to the Acutus Medical Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Acutus Medical to Announce Second Quarter 2022 Financial Results
GlobeNewsWire
28 июл 2022 г. в 16:01
CARLSBAD, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its second quarter 2022 financial results on Thursday, August 11, 2022. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.